A23V 2250/5034
Beta-glucan
Official title: Beta-Glucan
A23V2250/5034 (Beta-glucan) appears on 10 US grants and 19 published applications in this corpus.
Search patents in A23V- Granted patents
- 10
- Published applications
- 19
- Assignees
- 9
- Inventors
- 35
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 1 |
| 2013 | 2 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 3 |
| 2020 | 0 | 4 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Thickeners and nutritional products to promote safe swallowing for individuals with dysphagia and methods of making and using same2 Dec 2025US 12,484,605 B2Societe des Produits Nestle S. A.
- Nutritional compositions containing milk-derived peptides and uses thereof16 May 2023US 11,647,778 B2Mead Johnson Nutrition Company
- Oral delivery compositions for improved gut barrier protection and immunity in mammals14 Jun 2022US 11,357,802 B2Vets Plus, Inc.
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function3 Nov 2015US 9,173,926 B2OmniGen Research, LLC
- Particulate-soluble glucan preparation14 Oct 2014US 8,859,759 B2Biothera, Inc.
- Thickeners and nutritional products to promote safe swallowing for individuals with dysphagia and methods of making and using same8 Sep 2022US 2022/0279828 A1Societe des Produits Nestle S. A.
- Dietary Supplement Comprising Beta-Glucan and Casein Hydrolysate for Improving Health and Growth Performance in a Mammal2 Sep 2021US 2021/0267249 A1University College Dublin, National University of Ireland, Dublin
- Nutritional compositions containing milk-derived peptides and uses thereof31 Dec 2020US 2020/0404957 A1Mead Johnson Nutrition Company
- Endoglucanase-treated glucans24 Sep 2020US 2020/0296992 A1
- Composition of dietary supplements and methods of making thereof10 Sep 2020US 2020/0281242 A1
Most cited
By later US patents
- Particulate-soluble glucan preparation14US 7,981,447 B2Biothera, Inc. · 2011
- Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function6US 8,236,303 B2OmniGen Research, LLC · 2012
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function5US 8,568,715 B2OmniGen Research, LLC · 2013
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function5US 8,834,868 B2OmniGen Research, LLC · 2014
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function3US 9,173,926 B2OmniGen Research, LLC · 2015